StockData
Definitive Healthcare Corp. logo

Definitive Healthcare Corp. (DH) company profile

DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3067% below fair value
$1.31+0.06 (+4.80%)

Close on Nov 13, 2026Market cap $139.84MP/E –Yield –

About Definitive Healthcare

Services-Prepackaged Software, SIC 7372

Definitive Healthcare Corp. provides a healthcare commercial intelligence platform that delivers data, analytics, and insights across the healthcare ecosystem. The company offers subscription-based access to comprehensive intelligence on healthcare providers, facilities, physicians, and organizations. Its platform enables clients to analyze market trends, optimize commercial strategies, identify key decision-makers, and enhance sales and marketing operations within the complex healthcare industry. Definitive Healthcare serves diverse commercial clients, including biopharmaceutical companies, medical device manufacturers, healthcare information technology firms, healthcare providers, and various professional services organizations that sell into or navigate the healthcare sector.

The company operates primarily within the United States while serving customers and tracking data across various international markets. Definitive Healthcare maintains its corporate headquarters in Framingham, Massachusetts.

Summary of the business section of Definitive Healthcare's latest annual report, written by StockData.

Company profile

Company

Legal name
Definitive Healthcare Corp.
Headquarters
Framingham, MA
Address
492 Old Connecticut Path, Suite 401 01701
Phone
(508) 720-4224
Employees
686, Dec 31, 2025
Industry
Services-Prepackaged Software
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Boston, MA

Stock & identifiers

Ticker
DH
Exchange
Nasdaq
IPO date
Sep 16, 2021
Shares outstanding
107M, Aug 6, 2026
Public float
$153.80M, Jun 30, 2025
Filer category
Accelerated filer<br>Smaller reporting company
SEC CIK
1861795
CUSIP
24477E103
ISIN
US24477E1038
FIGI
BBG01282ZJM7
Share class FIGI
BBG01282ZKG1
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Clay Brian RitcheyChief Executive Officer, Director2,631,263
Kevin CoopChief Executive Officer, Director4,975,229
Casey HellerChief Financial Officer1,784,079
Jonathan ParisChief Legal Officer864,534
Benjamin GraboskeEVP, Chief Data Officer1,312,027
Kate Marie ShamsuddinCHIEF OPERATING OFFICER694,149
Richard Douglas BoothCHIEF FINANCIAL OFFICER652,630
William MoschellaChief Product & Tech Officer451,302
Jason Ronald KrantzDirector2,077,106
Samuel A. HamoodDirector340,978
Scott G. StephensonDirector313,314
Sastry ChilukuriDirector315,984
Kathleen A. WintersDirector308,982
Jill LarsenDirector114,751

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$8.60M$5.30M$3.70M$26–
FY2024
Coop
$10.88M$7.72M$4.55M$37–
FY2024
Krantz
$10.36M$424.31K$4.55M$37–
FY2024
Musslewhite
$6.81M-$4.68M$4.55M$37–
FY2023$8.43M$3.15M$2.81M$90–
FY2022$820.93K-$10.36M$2.39M$25$45

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Kevin Coop
Chief Executive Officer
$500.00K–$7.70M$384.88K$22.52K$8.60M-21%
Casey Heller
Chief Financial Officer
$362.31K–$3.45M$146.08K$14.23K$3.97M+153%
Benjamin Graboske
EVP Technology and Engineering, Chief Data Officer
$318.37K$20.00K$2.88M$185.12K$11.78K$3.42M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Sep 16, 2021
Offer price
$27.00
Securities offered
15,555,555
Gross proceeds
$420.00M
Exchange
Nasdaq
First trading day
Sep 15, 2021
First-day close
$43.29+60.3%
Lock-up ends (est.)
Mar 14, 2022

“The initial public offering price per share is $27.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, our workforce included 686 employees — of whom 678 were employed full time.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?